Generics 4

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Granulocyte colony stimulating factor, recombinant human manufacturers

4 products found

Filters

4 products found

granulocyte colony stimulating factor, recombinant human

Solution for injection 7.5 IU/mL, 15 IU/mL, 20 IU/mL, 30 IU/mL

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #17374
It is a company specializing in the area of life sciences concerned with collective and individual health and well-being. The mission of the company is to simplify and democratize access to treatments and products through partnerships and qualified suppliers.

granulocyte colony stimulating factor, recombinant human

Solution for injection 75mcg, 150mcg, 300mcg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #16892
This company is a global product and service provider specializing in the chemical and pharmaceutical industries. They import and export a wide range of products, including pharmaceutical raw materials, intermediates, dyes, pesticides, basic chemicals, fine chemicals, food additives, and medical preparations. They also offer technical services such as research and customization for the chemical and pharmaceutical sectors, along with testing services that encompass safety, quality control, and composition analysis. While their primary focus is on supplying these products to various regions across the globe, including North America, Europe, and Asia, they are actively expanding into new markets.

Manufacturer usually replies in 5 days

granulocyte colony stimulating factor, recombinant human

Vials, injection 75 μg/0.5 ml, 150 μg/0.5 ml, 300 μg/1 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #31065

This biopharmaceutical company specializes in the research, development, production, and marketing of recombinant protein therapeutics and microecological agents. They focus on treating a range of conditions including antiviral, oncology, immunology, hematology, digestive disorders, and degenerative diseases. The company boasts seven world-leading technology platforms, including recombinant protein secretion and expression, long-acting recombinant proteins, and antibody technology. Their product portfolio includes recombinant protein therapeutics such as Human Erythropoietin (EPOSINO), Human Interferon α1b (SINOGEN), and Human Granulocyte Colony-stimulating Factor (WHITE-C), as well as the microecological agent "Combined Clostridium Butyricum and Bifidobacterium (CLOBICO)". The company has a strong presence in major markets such as North America, the EU, Brazil, the Philippines, and Indonesia.

Manufacturer usually replies in 7 days

Want to see all 4 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible